FEATURED

The COVAX Humanitarian Buffer: Explained

The COVAX Humanitarian Buffer has made its first delivery, sending over a million doses to Iran for Afghan refugees in the country. But what is the Buffer and why is it so important?

26 Nov 2021 | 1:06

RELATED TOPICS

LATEST

SELECTED

All videos

29 January 2021

How much of an impact do vaccines really have?

The world’s most comprehensive study reveals all! A new study looking at the impact of vaccinations in 98 countries over the past 20 years concludes that 37 million people are alive today thanks to vaccines.

26 January 2021

Hesitancy over new COVID-19 vaccines doesn’t seem likely to affect uptake

The initial concern that nervousness over the new vaccines would slow uptake doesn’t seem to have become a reality in the early days of COVID-19 immunisation, although it will be critical to maintain vaccine confidence suggests an Ipsos poll.

12 January 2021

From biodefence to the DRC: How the Ebola vaccine became one of the fastest vaccines to license in history

COVID-19 vaccines are set to become the quickest vaccines in history to go from initial trials to rollout, but what lessons can we learn from its speedy predecessor: the Ebola vaccine?

6 January 2021

COVID-19 FAQs: The 10 questions you need to know the answer to

We believe the best way to address misconceptions is to arm yourself with the facts and have a few key points and statistics. Here’s our list of facts to combat common misinformation.

30 December 2020

Seven vital questions about RNA Covid-19 vaccines

The Pfizer-BioNTech and Moderna Covid-19 vaccines are more than 90% effective, as reported in phase III clinical trials – and the Pfizer-BioNTech vaccine is the first Covid-19 vaccine to be licensed.

28 December 2020

Severe COVID may be caused by 'autoantibodies' – here is what that means

Antibodies that go rogue and attack healthy tissue identified in patients with severe COVID.

18 December 2020

There are four types of COVID-19 vaccines: here’s how they work

The fight against COVID-19 has seen vaccine development move at record speed, with more than 170 different vaccines in trials. But how are they different from each other and how will they protect us against the disease?

17 December 2020

How did scientists manage to develop safe COVID-19 vaccines in just ten months?

The COVID-19 vaccines currently rolling off production lines have been developed faster than any other vaccine against a new disease in history. How have scientists achieved this incredible feat? And could the lessons learned enable more rapid…

16 December 2020

Why get vaccinated when the flu vaccine doesn’t work well?

The best way we can prevent flu infection is by getting vaccinated. The problem with the flu vaccine is that in some years it doesn’t work as well as others.

16 December 2020

2020 Year in Review: The impact of COVID-19 in 12 charts

12 charts provide an overview of our research in the face of a truly unprecedented crisis.

15 December 2020

Getting girls on board with the HPV vaccine

New girl-centered toolkit helps health officials develop and implement communications campaigns that resonate with girls in their countries.

7 December 2020

Routine vaccinations during a pandemic – benefit or risk?

Some countries may stop their vaccination programs for a while to reduce the risk of spreading COVID-19. But which is better: fewer coronavirus infections or making sure children get all their usual vaccinations?

Last updated: 29 Nov 2021